186 results
Page 4 of 10
6-K
EX-99.7
z0717x548x7d5w1
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
egcgl3u4 8rlxmpe974
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
v20y451xu14ubk vk45v
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
z1cgav336k7p5a
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
ghlxb2xqm6qjrl u63
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
d9art5utv qmowv
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
p5a5 7ol5iw5
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
zvbiy262eflga36hqlbi
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
kg0aalx91lk
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.1
0gykkipk16 80h
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
u5k2s
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
coo7nk4
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
jda4n7qw021e6xbh76
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
h1whswlo1t
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
c1aerm yvkceq
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
6yvfe 3whlj
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
gqx2j rhd
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
y3u206z8 nq8fldv
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm